N-Acetyl-L-Cysteine (NAC) — Glutathione and detox

Quick summary

The N-acetyl-L-cysteine (NAC) It is the stable and bioavailable form of the amino acid cysteine, the limiting substrate for the endogenous synthesis of glutathione (GSH), the most abundant intracellular antioxidant. It is one of the compounds with the most accumulated clinical evidence in hepatology, pulmonology, and psychiatry, and remains the first-line antidote for paracetamol poisoning in hospitals around the world.

Mechanism of action

NAC delivers free cysteine to cells after intracellular deacetylation. Once inside:

• Glutathione precursor: It provides the limiting thiol group (–SH) for GSH synthesis in the liver, lungs, and brain.
• Direct antioxidant: neutralizes free radicals (•OH, ONOO⁻) and reactive nitrogen species.
• Mucolytic: It breaks disulfide bonds of mucoproteins in bronchial mucus, thinning it.
• Glutamatergic modulator: It regulates the cystine/glutamate exchanger (xc- system) in the CNS, with an impact on compulsion, anxiety, and craving.
• Heavy metal chelator: It supports the excretion of mercury, lead, and cadmium via thiol-metal complexes.

Clinical evidence

Robust evidence

• Antidote for paracetamol poisoning: Prescott LF (BMJ, 1979) — standard hospital clinical use.
• COPD and exacerbations: Decramer M et al. (Lancet, 2005, BRONCUS) — modulation of bronchial exacerbations.
• Obsessive-compulsive spectrum psychiatric disorders: Berk M et al. (Biol Psychiatry, 2008) — reduction of symptoms in bipolar disorder and compulsive disorder.

Plausible / suggested

• Support in COPD, pulmonary fibrosis and post-COVID lung injury (Tieu S et al., Antioxidants, 2022).
• Reduction of craving in addictions (cocaine, tobacco) — small studies.
• Improvement of male fertility (seminal parameters).
• Support for non-alcoholic fatty liver disease.

Speculative / preclinical

• Neuroprotection against Parkinson's and Alzheimer's (animal models).
• Modulation of cellular senescence via mitochondrial GSH rescue.

Molecular form and bioavailability

Free cysteine is unstable and has poor bioavailability when taken orally. acetylation The amino group protects it from first-pass metabolism and increases intestinal absorption. Tmax ≈ 1–2 h, oral bioavailability ≈ 6–101 TP3T, but sufficient to elevate intracellular GSH. Better absorption on an empty stomach or between meals; high-protein foods can compete for transporters.

Limitations and what it DOES NOT do

• It does not replace injectable glutathione In severe liver diseases —it is a precursor, not the final molecule.
• The sulfur smell is inherent to the molecule; it is not a product defect.
• It is not an antioxidant for "general cleaning" — its logic is specific biochemistry.
• In people with high GSH and no oxidative stressors, the marginal benefit is low.

Target population

• Adults with regular alcohol consumption, chronic paracetamol use, or exposure to liver toxins.
• Smokers and ex-smokers with compromised lung function.
• High-load athletes (increased oxidative stress).
• Nutritional support in compulsive/craving profiles (always as a complement, not a substitute, for psychiatric treatment).